Global Immuno-Oncology Market by Type (Cancer Vaccines, Checkpoint Inhibitors, Cytokines), Indication (Breast Cancer, Colorectal Cancer, Lung Cancer), End-Users - Forecast 2024-2030- Product Image

Sale

Global Immuno-Oncology Market by Type (Cancer Vaccines, Checkpoint Inhibitors, Cytokines), Indication (Breast Cancer, Colorectal Cancer, Lung Cancer), End-Users - Forecast 2024-2030

Report
196 Pages
March 2024
Region: Global
360iResearch™
ID: 5889363

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Immuno-Oncology Market size was estimated at USD 5.36 billion in 2023, USD 5.89 billion in 2024, and is expected to grow at a CAGR of 9.99% to reach USD 10.45 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immuno-Oncology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immuno-Oncology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immuno-Oncology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Adaptimmune Therapeutics PLC, Adicet Bio, Inc., Agilent Technologies, Inc., Allogene Therapeutics, Amgen Inc., Arcus Biosciences, Inc., Asher Biotherapeutics, Inc., Astellas Pharma Inc., AstraZeneca PLC, Atara Biotherapeutics, Inc., Autolus Therapeutics PLC, Avantor, Inc., BeiGene, Inc., Bio-Rad Laboratories, Inc., BioNTech SE, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Cellectis SA, F. Hoffmann-La Roche AG, Fate Therapeutics Inc., Merck KGaA, Sanofi S.A., Thermo Fisher Scientific Inc., and Triumvira Immunologics Inc.

Market Segmentation & Coverage

This research report categorizes the Immuno-Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Cancer Vaccines
- Checkpoint Inhibitors
- Cytokines
- Immune Cell Therapy (CAR-T)
- Monoclonal Antibodies
Indication
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Melanoma
End-Users
- Academic & Research Institutions
- Hospitals & Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Immuno-Oncology Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immuno-Oncology Market?
What are the technology trends and regulatory frameworks in the Immuno-Oncology Market?
What is the market share of the leading vendors in the Immuno-Oncology Market?
Which modes and strategic moves are suitable for entering the Immuno-Oncology Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Immuno-Oncology Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing burden of cancer cases across the globe
5.1.1.2. Favorable government initiatives for cancer management
5.1.1.3. Growing preference for immunotherapy and targeted therapies
5.1.2. Restraints
5.1.2.1. Associated high medical expenses of immuno-oncology
5.1.3. Opportunities
5.1.3.1. Surge in fundings for research and development activities
5.1.3.2. Expansion of personalized medicine and precision oncology
5.1.4. Challenges
5.1.4.1. Concern regarding adverse health impacts of immuno-oncology
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Immuno-Oncology Market, by Type

6.1. Introduction
6.2. Cancer Vaccines
6.3. Checkpoint Inhibitors
6.4. Cytokines
6.5. Immune Cell Therapy (CAR-T)
6.6. Monoclonal Antibodies

7. Immuno-Oncology Market, by Indication

7.1. Introduction
7.2. Breast Cancer
7.3. Colorectal Cancer
7.4. Lung Cancer
7.5. Melanoma

8. Immuno-Oncology Market, by End-Users

8.1. Introduction
8.2. Academic & Research Institutions
8.3. Hospitals & Clinics

9. Americas Immuno-Oncology Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Immuno-Oncology Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Immuno-Oncology Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Adaptimmune Therapeutics PLC
13.1.3. Adicet Bio, Inc.
13.1.4. Agilent Technologies, Inc.
13.1.5. Allogene Therapeutics
13.1.6. Amgen Inc.
13.1.7. Arcus Biosciences, Inc.
13.1.8. Asher Biotherapeutics, Inc.
13.1.9. Astellas Pharma Inc.
13.1.10. AstraZeneca PLC
13.1.11. Atara Biotherapeutics, Inc.
13.1.12. Autolus Therapeutics PLC
13.1.13. Avantor, Inc.
13.1.14. BeiGene, Inc.
13.1.15. Bio-Rad Laboratories, Inc.
13.1.16. BioNTech SE
13.1.17. Boehringer Ingelheim International GmbH
13.1.18. Bristol Myers Squibb
13.1.19. Cellectis SA
13.1.20. F. Hoffmann-La Roche AG
13.1.21. Fate Therapeutics Inc.
13.1.22. Merck KGaA
13.1.23. Sanofi S.A.
13.1.24. Thermo Fisher Scientific Inc.
13.1.25. Triumvira Immunologics Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. IMMUNO-ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 2. IMMUNO-ONCOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNO-ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNO-ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNO-ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNO-ONCOLOGY MARKET DYNAMICS
FIGURE 7. IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. IMMUNO-ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. IMMUNO-ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. IMMUNO-ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNO-ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNO-ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. IMMUNO-ONCOLOGY MARKET SIZE, BY CANCER VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNO-ONCOLOGY MARKET SIZE, BY CHECKPOINT INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNO-ONCOLOGY MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNO-ONCOLOGY MARKET SIZE, BY IMMUNE CELL THERAPY (CAR-T), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IMMUNO-ONCOLOGY MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. IMMUNO-ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNO-ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNO-ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. IMMUNO-ONCOLOGY MARKET SIZE, BY MELANOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 17. IMMUNO-ONCOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNO-ONCOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 29. CANADA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. CANADA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. CANADA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 32. MEXICO IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. MEXICO IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES IMMUNO-ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 46. CHINA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. CHINA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. CHINA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 49. INDIA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. INDIA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. INDIA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 55. JAPAN IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. JAPAN IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. JAPAN IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 73. THAILAND IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. THAILAND IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. THAILAND IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. DENMARK IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. DENMARK IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 86. EGYPT IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. EGYPT IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. EGYPT IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 89. FINLAND IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. FINLAND IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. FINLAND IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 92. FRANCE IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FRANCE IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. FRANCE IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 95. GERMANY IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. GERMANY IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. GERMANY IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 101. ITALY IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ITALY IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 103. ITALY IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 110. NORWAY IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NORWAY IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. NORWAY IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 113. POLAND IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. POLAND IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. POLAND IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 116. QATAR IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. QATAR IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 118. QATAR IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 128. SPAIN IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SPAIN IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 130. SPAIN IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 137. TURKEY IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. TURKEY IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. TURKEY IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM IMMUNO-ONCOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM IMMUNO-ONCOLOGY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM IMMUNO-ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 146. IMMUNO-ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 147. IMMUNO-ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. IMMUNO-ONCOLOGY MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Adaptimmune Therapeutics PLC
Adicet Bio, Inc.
Agilent Technologies, Inc.
Allogene Therapeutics
Amgen Inc.
Arcus Biosciences, Inc.
Asher Biotherapeutics, Inc.
Astellas Pharma Inc.
AstraZeneca PLC
Atara Biotherapeutics, Inc.
Autolus Therapeutics PLC
Avantor, Inc.
BeiGene, Inc.
Bio-Rad Laboratories, Inc.
BioNTech SE
Boehringer Ingelheim International GmbH
Bristol Myers Squibb
Cellectis SA
F. Hoffmann-La Roche AG
Fate Therapeutics Inc.
Merck KGaA
Sanofi S.A.
Thermo Fisher Scientific Inc.
Triumvira Immunologics Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	196
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.89 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.45 Billion
Compound Annual Growth Rate	9.9%
Regions Covered	Global
No. of Companies Mentioned	25

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase II, Phase III), Indication - Forecast 2024-2030

Global Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Forecast 2024-2030

Immuno-Oncology Clinical Trials Market Report 2023-2033

Immuno-Oncology - Global Strategic Business Report

Immuno-Oncology Drugs Global Market Report 2024